Stocks›Healthcare›LAB

LAB

Standard BioTools Inc.

NasdaqResearch view

Healthcare · Pharmaceutical Preparations · Small-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$302.2M

Enterprise Value$179.2M

Income$-74.9M

Sales$85.3M

Book/sh$1.08

Cash/sh$0.31

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio4.01

Current Ratio4.19

Debt/Eq0.00

EPS (ttm)$-0.20

EPS this Y61.5%

EPS past 3/5Y—

Sales past 3/5Y-4.5%

EPS Y/Y TTM61.5%

Sales Y/Y TTM-6.2%

Shs Outstand392.58M

ROA-13.2%

ROE-17.7%

ROIC-22.2%

Gross Margin49.9%

Oper. Margin-129.2%

Profit Margin-87.8%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$130.6M

2021

$97.9M

2022

$106.3M

2023

$91.0M

2024

$85.3M

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$130.6M	$97.9M	$106.3M	$91.0M	$85.3M
Gross Profit	—	$37.1M	$50.5M	$44.9M	$42.5M
Operating Income	$-67.5M	$-116.2M	$-76.6M	$-127.5M	$-110.2M
Net Income	$-59.2M	$-190.1M	$-74.7M	$-138.9M	$-74.9M
Diluted EPS	$-0.78	$-2.43	$-0.94	$-0.52	$-0.20
Operating Cash Flow	$-44.1M	$-89.4M	$-43.3M	$-143.5M	$-74.3M
Free Cash Flow	$-57.3M	$-93.2M	$-46.1M	$-151.8M	$-82.6M